TARGETing Neuroblastoma: ARRA Funds Supporting Childhood Cancer Research

This video shows how the American Reinvestment and Recovery Act (Recovery Act) funds are accelerating research to develop better treatment strategies for cancer patients. The goal of genomic research is to identify the genetic changes that occur in specific cancers and develop treatment strategies that target those genetic changes. This personalized treatment strategy aims to improve treatment effectiveness and reduce side effects by attacking the disease where it starts -- in the genes. For 5-year-old Haley, cancer research is striving to keep her Neuroblastoma, a cancer in immature nerve cells, in remission and eliminate the life-long side effects of traditional treatments by replacing it with genetically informed medicine also known as personalized medicine.


It is with a heavy heart that we announce the passing of Hayley Kudro on December 27, 2011. We at the National Cancer Institute feel honored to have been a part of her life story. To view the "Targeting Neuroblastoma (epilogue)" please visit: http://www.youtube.com/watch?v=o5So6gEFxso

Category:

Science & Technology

Tags:

• Neuroblastoma
• NCI
• Cancer
• Pediatric
• John Maris
• personalized Medicine
• Cancer research
• hayley kudro
• Karen kudro
• national cancer institute
• CHOP
• recovery act
• childhood cancer
• TARGET
• National institutes of health
• health and human services